Position in TMO
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$241,154
+$26,847 QoQ
Shares Held
481
+10.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#2,167
of 2,606 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PFG Advisors holds $7,982,517 across 5 Diagnostics & Research names. TMO ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
19,699 | $3,752,265 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
5,172 | $2,722,747 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
3,771 | $728,632 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
2,371 | $537,719 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
This page
|
481 | $241,154 |
All Filings in TMO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $241,154 | 481 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $214,307 | 436 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $259,014 | 447 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $309,442 | 638 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $259,899 | 641 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||